Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Individuals with a BMI of 27 kg/m or greater (classified as overweight) who also have at least one weight-related comorbidity, such as high blood pressure, type 2 diabetes, or high cholesterol
Knowing your baseline before starting, and monitoring changes over time, helps you and your clinician make informed dosing decisions
This conception has been changing during recent years, since it has been reported that resistance to GIP can be reversed and its effectiveness restored by improving glycemic control
What the Research Says BPC-157: Evidence Overview What the Research Supports (Animal Models) The majority of BPC-157 research has been conducted in rodent models and has demonstrated: Accelerated healing of tendon, ligament, and muscle injuries Gastroprotective effects against NSAID-induced ulcers and inflammatory bowel lesions Neuroprotection in models of traumatic brain injury and peripheral nerve damage Systemic anti-inflammatory activity Bone healing support and osteoblast activity enhancement The animal research for BPC-157 is genuinely compelling in breadth
